(Q40433213)

20 September 2017

1 reference

title

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease (English)

1 reference

20 September 2017

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

30 May 2024

0 references

0 references

0 references

1 reference

4

R. O. Williams

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

8

P. C. Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

author name string

R. N. Maini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

M. J. Elliott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

F. M. Brennan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

C. Q. Chu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

E. Paleolog

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

P. J. Charles

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

M. Feldmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590814

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590814

30 May 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00070.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00070.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

144

1 reference

20 September 2017

195-223

1 reference

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Clinical management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Circulating adhesion molecules in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

An interleukin 1 like factor stimulates bone resorption in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Monoclonal antibody-defined human endothelial antigens as vascular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Biology of the rantes/sis cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00070.X

Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis

30 May 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures

30 May 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Cytokine expression in rheumatoid arthritis

30 May 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Management of early inflammatory arthritis. Intervention with immunomodulatory agents: monoclonal antibody therapy

30 May 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

30 May 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair

30 May 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

High level of interleukin-10 production by the activated t cell population within the rheumatoid synovial membrane

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

30 May 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta

30 May 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Adhesion molecules in the pathogenesis of rheumatoid arthritis

30 May 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis

30 May 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis

30 May 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

30 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

New directions for biological therapy in rheumatoid arthritis

30 May 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study

30 May 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

How important are T cells in chronic rheumatoid synovitis?

30 May 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Lymphocyte-endothelial interactions in inflamed synovia: involvement of several adhesion molecules and integrin epitopes

30 May 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

30 May 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha

30 May 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Monoclonal anti-CD4 in arthritis

30 May 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

New therapeutic approaches in rheumatoid arthritis

30 May 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis

30 May 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities

30 May 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Humanised monoclonal antibody therapy for rheumatoid arthritis

30 May 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Adhesion molecule expression in human synovial tissue

30 May 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

30 May 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Soluble E-Selectin in Arthritis

30 May 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis

30 May 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Incidence of rheumatoid arthritis: do the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis?

30 May 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion mo

30 May 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Treatment with gamma-interferon triggers the onset of collagen arthritis in mice.

30 May 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis

30 May 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

30 May 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins

30 May 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Evidence for the effects of a superantigen in rheumatoid arthritis

30 May 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Induction of nitric oxide synthase in human chondrocytes

30 May 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

30 May 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group

30 May 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells

30 May 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Local anti—type ii collagen antibody production in rheumatoid arthritis synovial fluid

30 May 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Mechanisms of erythroid suppression in the anemia of chronic disease

30 May 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Twin concordance rates for rheumatoid arthritis: results from a nationwide study.

30 May 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Divergent T-cell cytokine patterns in inflammatory arthritis

30 May 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Collagen autoimmune arthritis

30 May 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis

30 May 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice

30 May 2024

91

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Effects of oral administration of type II collagen on rheumatoid arthritis

30 May 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment

30 May 2024

93

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

The pathophysiology of tumor necrosis factors

30 May 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Monoclonal antibodies in diagnosis and therapy

30 May 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus

30 May 2024

97

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

30 May 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis

30 May 2024

101

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice

30 May 2024

103

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00070.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference